Invesaro

Stocks Comparison

Charles River Laboratories International vs Icon: revenue, profit, margins and growth compared

Charles River Laboratories International brought in $4B of revenue in fiscal 2025, Icon $8.3B in fiscal 2025. Revenue changed by -0.9% at Charles River Laboratories International and +0.8% at Icon on the year before, so Icon grew faster. Charles River Laboratories International kept -3.6% of its revenue as net profit, Icon 2.8%. Free cash flow was $518.5M at Charles River Laboratories International and $862M at Icon.

Open the CRL pageOpen the ICLR page

Side by side, latest fiscal year

CRLICLR
Fiscal year endedFY2025 (December 27, 2025)FY2025 (December 31, 2025)
Revenue$4B$8.3B
Revenue growth-0.9%+0.8%
Net income-$144.3M$229.3M
Net margin-3.6%2.8%
Free cash flow$518.5M$862M
Free cash flow margin12.9%10.4%
Earnings per share (diluted)-$2.91$2.90
Cash$213.8M$647.3M
Debt$166K$2.9B
Price to earningsn/an/a
Market value$14B$13.2B
Dividend yieldn/an/a
Rank by revenue in sector#72 of 523 · Health care#50 of 523 · Health care

Over the years

Revenue
CRL FY2018: $2.3BCRL FY2019: $2.6BCRL FY2020: $2.9BCRL FY2021: $3.5BCRL FY2022: $4BCRL FY2023: $4.1BCRL FY2024: $4BCRL FY2025: $4BICLR FY2018: $2.6BICLR FY2019: $2.8BICLR FY2020: $2.8BICLR FY2021: $5.5BICLR FY2022: $7.7BICLR FY2023: $8.1BICLR FY2024: $8.2BICLR FY2025: $8.3BFY18FY19FY20FY21FY22FY23FY24FY25
CRL $4BICLR $8.3B
Net income
CRL FY2018: $226.4MCRL FY2019: $252MCRL FY2020: $364.3MCRL FY2021: $391MCRL FY2022: $486.2MCRL FY2023: $474.6MCRL FY2024: $22.2MCRL FY2025: -$144.3MICLR FY2018: $322.7MICLR FY2019: $374MICLR FY2020: $332.3MICLR FY2021: $153.2MICLR FY2022: $505.3MICLR FY2023: $554.2MICLR FY2024: $739.1MICLR FY2025: $229.3MFY18FY19FY20FY21FY22FY23FY24FY25
CRL -$144.3MICLR $229.3M
Net margin
CRL FY2018: 10.0%CRL FY2019: 9.6%CRL FY2020: 12.5%CRL FY2021: 11.0%CRL FY2022: 12.2%CRL FY2023: 11.5%CRL FY2024: 0.5%CRL FY2025: -3.6%ICLR FY2018: 12.4%ICLR FY2019: 13.3%ICLR FY2020: 11.9%ICLR FY2021: 2.8%ICLR FY2022: 6.5%ICLR FY2023: 6.9%ICLR FY2024: 9.0%ICLR FY2025: 2.8%FY18FY19FY20FY21FY22FY23FY24FY25
CRL -3.6%ICLR 2.8%
Revenue growth
CRL FY2019: +15.7%CRL FY2020: +11.5%CRL FY2021: +21.1%CRL FY2022: +12.3%CRL FY2023: +3.9%CRL FY2024: -1.9%CRL FY2025: -0.9%ICLR FY2019: +8.1%ICLR FY2020: -0.3%ICLR FY2021: +95.9%ICLR FY2022: +41.2%ICLR FY2023: +4.1%ICLR FY2024: +1.7%ICLR FY2025: +0.8%FY19FY20FY21FY22FY23FY24FY25
CRL -0.9%ICLR +0.8%
Free cash flow
CRL FY2018: $301.1MCRL FY2019: $340.4MCRL FY2020: $380MCRL FY2021: $532MCRL FY2022: $294.9MCRL FY2023: $365.4MCRL FY2024: $501.6MCRL FY2025: $518.5MICLR FY2018: $220.2MICLR FY2019: $373.6MICLR FY2020: $527.2MICLR FY2021: $735.4MICLR FY2022: $421.2MICLR FY2023: $1BICLR FY2024: $1.1BICLR FY2025: $862MFY18FY19FY20FY21FY22FY23FY24FY25
CRL $518.5MICLR $862M

Fiscal years as each company reports them; the two may end in different months.

Questions about Charles River Laboratories International and Icon

Which is bigger by revenue, Charles River Laboratories International or Icon?

Icon is bigger by revenue: $8.3B in fiscal 2025, against $4B for Charles River Laboratories International in fiscal 2025.

Which keeps more of its revenue as profit, Charles River Laboratories International or Icon?

Charles River Laboratories International had a net margin of -3.6% in fiscal 2025; Icon had 2.8% in fiscal 2025.

Which grew revenue faster, Charles River Laboratories International or Icon?

In their latest fiscal years revenue changed by -0.9% at Charles River Laboratories International and +0.8% at Icon.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

CRL vs IQV
CRL vs INCY
CRL vs MEDP
ICLR vs IQV
ICLR vs INCY
ICLR vs MEDP

Compare more companies